Marucci, M.A., Lechner , D.W. and Tafuto , B.A. 2024. Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review. Gastrointestinal Tract. 2, 1 (Mar. 2024). DOI:https://doi.org/10.54844/git.2023.482.